FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Ivy sticks out its powerful grasp to science May 24, 10:30 am
Washington D.C, May 24 (ANI): The powerful grasp of English ivy can lead to better medical adhesives, stronger armor for the military and maybe even cosmetics with better staying power.
Full Story
Loss of Y chromosome puts men at Alzheimer's risk May 24, 9:22 am
Washington D.C, May 24 (ANI): Soon, doctors will be able to tell you if you are at the risk for Alzheimer's disease by looking at your DNA, suggests a new study.
Full Story
Low- and high-birthweight babies at increased heart risk May 24, 7:54 am
Washington D.C, May 24 (ANI): If your baby has either a low birthweight or a high one, she/he may be at an increased risk for cardiovascular disease, according to a recent study.
Full Story
Text messages may help smokers kick the butt May 24, 7:29 am
Washington D.C, May 24 (ANI): The next time your phone dings, you could be reading a text message that inspires you to stub that cigarette butt.
Full Story
Comments